Tadeusz Hawrot

Aug 6, 2024 | drugscience.org.uk | David Nutt |Tadeusz Hawrot |Peter Hunt

AuthorsProf David J NuttImperial College London; Drug Science Tadeusz HawrotPAREAPeter HuntMind Medicine Australia Dr Anne Katrin SchlagImperial College London; Drug SciencePublishedAugust 6, 2024MDMA [now called midomafetamine by the FDA] is a substituted amphetamine first synthesized in 1912 by Merck that has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies (MAPS) as a novel treatment for post-traumatic stress disorder (PTSD).